Assistant Professor of Surgery, Johns Hopkins University School of Medicine; Director, Living Donor Transplantation
General Surgery
Dr. Nabil N. Dagher, MD
|
|
Give Review
Nabil Dagher works in the field of General Surgery. He went to medical school at Medical College of Wisconsin. Medical College of Wisconsin is ranked 54/62 in Research/PrimaryCare. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Nabil N. Dagher, MD is a published physician. He has 25 papers published. The most current publication "Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature." Dr. Nabil N. Dagher accepts Medicare.
Publications
- Magnetic Resonance Imaging in Diagnosis and Monitoring of Hepatocellular Carcinoma in Liver Transplantation: A Comprehensive Review.
- Surgical management of early and late ureteral complications after renal transplantation: techniques and outcomes.
- Sarcopenia Adversely Impacts Postoperative Complications Following Resection or Transplantation in Patients with Primary Liver Tumors.
- Expanding the donor pool for Liver transplants: a 2014 summary.
- Perioperative Complications After Live-Donor Hepatectomy.
- Donor-transmitted malignancy in a Liver transplant recipient: a case report and review of literature.
- The Aggressive Phenotype Revisited: Utilization of Higher-Risk Liver Allografts.
- Center-level factors and racial disparities in living donor kidney transplantation.
- Estimates of Early Death, Acute Liver Failure, and Long-term Mortality Among Live Liver Donors.
- Outcomes of renal transplants from centers for Disease control and prevention high-risk donors with prospective recipient viral testing: a single-center experience.
- Desensitization in HLA-incompatible kidney recipients and survival.
- Outcomes and discard of kidneys from pediatric donors after cardiac death.
- Increased risk of graft loss from hepatic artery thrombosis after Liver transplantation with older donors.
- The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib.
- Pharmacotherapy before and after reVascularization: anticoagulation, antiplatelet agents, and statins.
- Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI.
- Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants.
- Kidney transplantation in previous heart or lung recipients.
- Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation.
- Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients.
- Center-level patterns of indicated willingness to and actual acceptance of marginal kidneys.
- Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without Vascular access.
- Frailty and delayed graft function in kidney transplant recipients.
- Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature.
Schools
Medical College of Wisconsin
Procedures Preformed
- Colectomy
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Embolectomy, Thrombectomy, or Vessel Exploration
- Enterostomy (Laparoscopic or Open)
- View All
Conditions Treated
- Abdominal Pain
- Atelectasis
- Biliary Atresia
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Johns Hopkins University -
University of Texas Southwestern Medical School -
Medical College of Wisconsin
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1770753170 | |
| NPPES Provider LastName | DAGHER | |
| NPPES Provider FirstName | NABIL | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | General Surgery | |
| Total Claim Count | 38.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770753170 |
| Last Name Of The Provider | DAGHER |
| First Name Of The Provider | NABIL |
| View All |
Similar Doctors
|
|
Dr. John L. Flowers, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Adheesh A. Sabnis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose M. Hipolito, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Larry H. Lickstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Matsuura, MD |
|
|
Dr. Jinny S. Ha, MD |
|
|
Dr. Julie A. Freischlag, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gopal Aggarwal, MD |
|
|
Dr. Keli M. Turner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mehmet Uluer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn W. Shaw, MD |
|
|
Dr. Dana-Rachael La Kam, MD |
|
|
Dr. Jonathan T. Magruder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alessandro Paniccia, MD |
|
|
Ashraf I. Reyad, MB BCH |